Find Cyclobenzaprine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

FDF DossiersDRUG PRODUCT COMPOSITIONS

232RELATED EXCIPIENT COMPANIES

380EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

GLOBAL SALES INFORMATION

Annual Reports

NA

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 6202-23-9, Cyclobenzaprine hcl, Flexeril, Flexiban, Amrix, Lisseril
Molecular Formula
C20H22ClN
Molecular Weight
311.8  g/mol
InChI Key
VXEAYBOGHINOKW-UHFFFAOYSA-N
FDA UNII
0VE05JYS2P

Cyclobenzaprine
Cyclobenzaprine Hydrochloride is a centrally acting muscle relaxant, chemically similar to amitriptyline hydrochloride with antidepressant activity. The exact mechanism of action of cyclobenzaprine hydrochloride has not been fully determined. However, it primarily acts at the brain stem to reduce tonic somatic motor activity, influencing both gamma and alpha motor neurons. This leads to a reduction in muscle spasms.
1 2D Structure

Cyclobenzaprine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine;hydrochloride
2.1.2 InChI
InChI=1S/C20H21N.ClH/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20;/h3-6,8-14H,7,15H2,1-2H3;1H
2.1.3 InChI Key
VXEAYBOGHINOKW-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31.Cl
2.2 Other Identifiers
2.2.1 UNII
0VE05JYS2P
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Cyclobenzaprine

2. Flexeril

3. Lisseril

2.3.2 Depositor-Supplied Synonyms

1. 6202-23-9

2. Cyclobenzaprine Hcl

3. Flexeril

4. Flexiban

5. Amrix

6. Lisseril

7. 3-(5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethylpropan-1-amine Hydrochloride

8. Cyclobenzaprine (hydrochloride)

9. Mk 130 Hydrochloride

10. Proheptatriene Hydrochloride

11. Mk130 Hydrochloride

12. Proheptatriene Monohydrochloride

13. Tnx-102

14. Nsc-78206

15. Nsc-169900

16. Nsc-173379

17. 0ve05jys2p

18. Chebi:3997

19. 5-(3-dimethylaminopropylidene)dibenzo[a,e]cycloheptatriene Hydrochloride

20. 1-propanamine, 3-(5h-dibenzo(a,d)cyclohepten-5-ylidene)-n,n-dimethyl-, Hydrochloride

21. N,n-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine;hydrochloride

22. Cycloflex

23. Tensodox

24. Cloben

25. Cyben

26. Novo-cycloprine

27. Flexeril Hydrochloride

28. Dsstox_cid_25105

29. Dsstox_rid_80672

30. Dsstox_gsid_45105

31. Tabradol

32. Yurelax

33. Miosan

34. Mk-130 Hcl

35. Multi-relax

36. 10,11.delta.-amitriptyline Hydrochloride

37. Proheptatrien Monohydrochloride

38. Wln: L C676 Bhj B3n1&1 &gh

39. Nsc78206

40. 5h-dibenzo[a, N,n-dimethyl-, Hydrochloride

41. Nsc169900

42. Nsc173379

43. Sr-01000075761

44. Cyclobenzaprine Hydrochloride [usan]

45. Einecs 228-264-4

46. Cas-6202-23-9

47. Nsc 78206

48. Unii-0ve05jys2p

49. Nsc 169900

50. Nsc 173379

51. 10,11delta-amitriptyline Hydrochloride

52. 5h-dibenzo[a,.gamma.-propylamine, N,n-dimethyl-, Hydrochloride

53. N,d]cycloheptene-.delta.,5.gamma.-propylamine, Hydrochloride

54. Tonmya

55. 1-propanamine,d]cyclohepten-5-ylidene)-n,n-dimethyl-, Hydrochloride

56. N,d]cycloheptene-.delta.(sup5,.gamma.)-propylamine Hydrochloride

57. 5-[3-(dimethylamino)propylidene]-5h-dibenzo-[a,d]cycloheptene Hydrochloride

58. 3-(dibenzo[2,1-b:1',2'-e][7]annulen-11-ylidene)-n,n-dimethylpropan-1-amine;hydrochloride

59. Flexeril (tn)

60. Prestwick_790

61. Mfcd00079039

62. Cyclobenzaprine Hydrochloride [usan:usp]

63. Nortriptyline Impurity E

64. 5-(3-dimethylaminopropylidene)-5h-dibenzo-(a,d)cycloheptene Hydrochloride

65. N,n-dimethyl-5h-dibenzo(a,d)cycloheptene-delta(sup 5,gamma)-propylamine Hydrochloride

66. Schembl41376

67. Mls002153815

68. Mk-130 Hydrochloride

69. Spectrum1503207

70. Amy502

71. Tnx-102 Sl

72. Chembl1200636

73. Dtxsid2045105

74. Tnx-105

75. Hms1569i12

76. Hms1922i11

77. Pharmakon1600-01503207

78. Act06294

79. Bcp21781

80. Cyclobenzaprine Hydrochloride (usp)

81. Eur-1002

82. Hy-b0740

83. Tox21_110040

84. Tox21_500303

85. Ccg-39312

86. Nsc758414

87. S4283

88. 3-(5h-dibenzo(a,d)cyclohepten-5-ylidene)propyl(dimethyl)ammonium Chloride

89. Akos015906329

90. Tox21_110040_1

91. Ac-1916

92. Bcp9000565

93. Lp00303

94. Nsc-758414

95. Sb19022

96. 5h-dibenzo(a,d)cycloheptene-delta(sup 5)-gamma-propylamine, N,n-dimethyl-, Hydrochloride

97. 5h-dibenzo(a,d)cycloheptene-delta5,gamma-propylamine, N,n-dimethyl-, Hydrochloride

98. Ncgc00013841-01

99. Ncgc00013841-09

100. Ncgc00093752-01

101. Ncgc00093752-02

102. Ncgc00093752-03

103. Ncgc00093752-04

104. Ncgc00093752-05

105. Ncgc00095017-01

106. Ncgc00095017-02

107. Ncgc00095017-03

108. Ncgc00095017-04

109. Ncgc00260988-01

110. As-15745

111. Bc181325

112. Cyclobenzaprine Hydrochloride [mi]

113. Smr000326702

114. Cyclobenzaprine Hydrochloride [mart.]

115. Cyclobenzaprine Hydrochloride [vandf]

116. Eu-0100303

117. Ft-0603166

118. Sw196928-3

119. Cyclobenzaprine Hydrochloride [usp-rs]

120. Cyclobenzaprine Hydrochloride [who-dd]

121. A14255

122. C 4542

123. D00772

124. L10029

125. 202c239

126. A854881

127. Cyclobenzaprine Hydrochloride [orange Book]

128. Cyclobenzaprine Hydrochloride [usp Impurity]

129. Cyclobenzaprine Hydrochloride [usp Monograph]

130. Sr-01000075761-1

131. Sr-01000075761-6

132. W-105056

133. Q27106282

134. Cyclobenzaprine Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)

135. 3-(5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethylpropan-1-aminehydrochloride

136. 3-(5h-dibenzo[a,d]cyclohepten-5-ylidene)-n,n-dimethylpropan-1-amine Hydrochloride

137. Cyclobenzaprine Hydrochloride, European Pharmacopoeia (ep) Reference Standard

138. N,n-dimethyl-5h-dibenzo(a,d)cycloheptene-delta(5,gamma)-propylamine Hydrochloride

139. 3-(5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethylpropan-1-amine Hydrochloride (cyclobenzaprine Hydrochloride)

140. Cyclobenzaprine Hydrochloride Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material

141. N,n-dimethyl-5h-dibenzo(a,d)cycloheptene-(sup .delta.5,.gamma.)-propylamine Hydrochloride

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 311.8 g/mol
Molecular Formula C20H22ClN
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count1
Rotatable Bond Count3
Exact Mass311.1440774 g/mol
Monoisotopic Mass311.1440774 g/mol
Topological Polar Surface Area3.2 Ų
Heavy Atom Count22
Formal Charge0
Complexity365
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameAmrix
PubMed HealthCyclobenzaprine (By mouth)
Drug ClassesSkeletal Muscle Relaxant, Centrally Acting
Drug LabelAMRIX (Cyclobenzaprine Hydrochloride Extended-Release Capsules) is a skeletal muscle relaxant which relieves muscle spasm of local origin without interfering with muscle function. The active ingredient in AMRIX extended-release capsules is cycloben...
Active IngredientCyclobenzaprine hydrochloride
Dosage FormCapsule, extended release
RouteOral
Strength30mg; 15mg
Market StatusPrescription
CompanyIvax Intl

2 of 4  
Drug NameCyclobenzaprine hydrochloride
Drug LabelCyclobenzaprine hydrochloride is a white, crystalline tricyclic amine salt. It has a melting point of 217C, and a pKa of 8.47 at 25C. It is freely soluble in water and alcohol, sparingly soluble in isopropanol, and insoluble in hydrocarbon solven...
Active IngredientCyclobenzaprine hydrochloride
Dosage FormTablet; Capsule, extended release
Routeoral; Oral
Strength5mg; 7.5mg; 30mg; 10mg; 15mg
Market StatusTentative Approval; Prescription
CompanyVintage Pharms; Twi Pharms; Ranbaxy; Mylan Pharms; Jubilant Cadista; Mutual Pharm; Kvk Tech; Actavis Labs Fl; Orit Labs; Aurobindo Pharma; Prosam Labs; Pliva; Invagen Pharms; Par Pharm

3 of 4  
Drug NameAmrix
PubMed HealthCyclobenzaprine (By mouth)
Drug ClassesSkeletal Muscle Relaxant, Centrally Acting
Drug LabelAMRIX (Cyclobenzaprine Hydrochloride Extended-Release Capsules) is a skeletal muscle relaxant which relieves muscle spasm of local origin without interfering with muscle function. The active ingredient in AMRIX extended-release capsules is cycloben...
Active IngredientCyclobenzaprine hydrochloride
Dosage FormCapsule, extended release
RouteOral
Strength30mg; 15mg
Market StatusPrescription
CompanyIvax Intl

4 of 4  
Drug NameCyclobenzaprine hydrochloride
Drug LabelCyclobenzaprine hydrochloride is a white, crystalline tricyclic amine salt. It has a melting point of 217C, and a pKa of 8.47 at 25C. It is freely soluble in water and alcohol, sparingly soluble in isopropanol, and insoluble in hydrocarbon solven...
Active IngredientCyclobenzaprine hydrochloride
Dosage FormTablet; Capsule, extended release
Routeoral; Oral
Strength5mg; 7.5mg; 30mg; 10mg; 15mg
Market StatusTentative Approval; Prescription
CompanyVintage Pharms; Twi Pharms; Ranbaxy; Mylan Pharms; Jubilant Cadista; Mutual Pharm; Kvk Tech; Actavis Labs Fl; Orit Labs; Aurobindo Pharma; Prosam Labs; Pliva; Invagen Pharms; Par Pharm

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Antidepressive Agents, Tricyclic

Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. (See all compounds classified as Antidepressive Agents, Tricyclic.)


Muscle Relaxants, Central

A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)


Tranquilizing Agents

A traditional grouping of drugs said to have a soothing or calming effect on mood, thought, or behavior. Included here are the ANTI-ANXIETY AGENTS (minor tranquilizers), ANTIMANIC AGENTS, and the ANTIPSYCHOTIC AGENTS (major tranquilizers). These drugs act by different mechanisms and are used for different therapeutic purposes. (See all compounds classified as Tranquilizing Agents.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Muscle Relaxant [EPC]; Centrally-mediated Muscle Relaxation [PE]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 15M...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 15MG

USFDA APPLICATION NUMBER - 21777

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 30M...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 30MG

USFDA APPLICATION NUMBER - 21777

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Granulation

read-more
read-more

Controlled & Modified Release

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Topical

read-more
read-more

Solubilizers

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Lubricants & Glidants

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Parenteral

read-more
read-more

Co-Processed Excipients

read-more
read-more

Taste Masking

read-more
read-more

API Stability Enhancers

read-more
read-more

Empty Capsules

read-more
read-more

Emulsifying Agents

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Rheology Modifiers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Vegetarian Capsules

read-more
read-more

Coloring Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

STOCK RECAP #PipelineProspector

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 6202-23-9 / Cyclobenzaprine API manufacturers, exporters & distributors?

Cyclobenzaprine manufacturers, exporters & distributors 1

25

PharmaCompass offers a list of Cyclobenzaprine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cyclobenzaprine manufacturer or Cyclobenzaprine supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cyclobenzaprine manufacturer or Cyclobenzaprine supplier.

PharmaCompass also assists you with knowing the Cyclobenzaprine API Price utilized in the formulation of products. Cyclobenzaprine API Price is not always fixed or binding as the Cyclobenzaprine Price is obtained through a variety of data sources. The Cyclobenzaprine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Cyclobenzaprine

Synonyms

6202-23-9, Cyclobenzaprine hcl, Flexeril, Flexiban, Amrix, Lisseril

Cas Number

6202-23-9

Unique Ingredient Identifier (UNII)

0VE05JYS2P

About Cyclobenzaprine

Cyclobenzaprine Hydrochloride is a centrally acting muscle relaxant, chemically similar to amitriptyline hydrochloride with antidepressant activity. The exact mechanism of action of cyclobenzaprine hydrochloride has not been fully determined. However, it primarily acts at the brain stem to reduce tonic somatic motor activity, influencing both gamma and alpha motor neurons. This leads to a reduction in muscle spasms.

Cyclobenzaprine Manufacturers

A Cyclobenzaprine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cyclobenzaprine, including repackagers and relabelers. The FDA regulates Cyclobenzaprine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cyclobenzaprine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Cyclobenzaprine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Cyclobenzaprine Suppliers

A Cyclobenzaprine supplier is an individual or a company that provides Cyclobenzaprine active pharmaceutical ingredient (API) or Cyclobenzaprine finished formulations upon request. The Cyclobenzaprine suppliers may include Cyclobenzaprine API manufacturers, exporters, distributors and traders.

click here to find a list of Cyclobenzaprine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Cyclobenzaprine USDMF

A Cyclobenzaprine DMF (Drug Master File) is a document detailing the whole manufacturing process of Cyclobenzaprine active pharmaceutical ingredient (API) in detail. Different forms of Cyclobenzaprine DMFs exist exist since differing nations have different regulations, such as Cyclobenzaprine USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Cyclobenzaprine DMF submitted to regulatory agencies in the US is known as a USDMF. Cyclobenzaprine USDMF includes data on Cyclobenzaprine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cyclobenzaprine USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Cyclobenzaprine suppliers with USDMF on PharmaCompass.

Cyclobenzaprine JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Cyclobenzaprine Drug Master File in Japan (Cyclobenzaprine JDMF) empowers Cyclobenzaprine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Cyclobenzaprine JDMF during the approval evaluation for pharmaceutical products. At the time of Cyclobenzaprine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Cyclobenzaprine suppliers with JDMF on PharmaCompass.

Cyclobenzaprine WC

A Cyclobenzaprine written confirmation (Cyclobenzaprine WC) is an official document issued by a regulatory agency to a Cyclobenzaprine manufacturer, verifying that the manufacturing facility of a Cyclobenzaprine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cyclobenzaprine APIs or Cyclobenzaprine finished pharmaceutical products to another nation, regulatory agencies frequently require a Cyclobenzaprine WC (written confirmation) as part of the regulatory process.

click here to find a list of Cyclobenzaprine suppliers with Written Confirmation (WC) on PharmaCompass.

Cyclobenzaprine NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cyclobenzaprine as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Cyclobenzaprine API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Cyclobenzaprine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Cyclobenzaprine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cyclobenzaprine NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Cyclobenzaprine suppliers with NDC on PharmaCompass.

Cyclobenzaprine GMP

Cyclobenzaprine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Cyclobenzaprine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cyclobenzaprine GMP manufacturer or Cyclobenzaprine GMP API supplier for your needs.

Cyclobenzaprine CoA

A Cyclobenzaprine CoA (Certificate of Analysis) is a formal document that attests to Cyclobenzaprine's compliance with Cyclobenzaprine specifications and serves as a tool for batch-level quality control.

Cyclobenzaprine CoA mostly includes findings from lab analyses of a specific batch. For each Cyclobenzaprine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Cyclobenzaprine may be tested according to a variety of international standards, such as European Pharmacopoeia (Cyclobenzaprine EP), Cyclobenzaprine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cyclobenzaprine USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty